Literature DB >> 32738213

Rapid, direct detection of bacterial topoisomerase 1-DNA adducts by RADAR/ELISA.

Devapriya Sinha1, Kostantin Kiianitsa2, David R Sherman3, Nancy Maizels4.   

Abstract

Topoisomerases are proven drug targets, but antibiotics that poison bacterial Topoisomerase 1 (Top1) have yet to be discovered. We have developed a rapid and direct assay for quantification of Top1-DNA adducts that is suitable for high throughput assays. Adducts are recovered by "RADAR fractionation", a quick, convenient approach in which cells are lysed in chaotropic salts and detergent and nucleic acids and covalently bound adducts then precipitated with alcohol. Here we show that RADAR fractionation followed by ELISA immunodetection can quantify adducts formed by wild-type and mutant Top1 derivatives encoded by two different bacterial pathogens, Y. pestis and M. tuberculosis, expressed in E. coli or M. smegmatis, respectively. For both enzymes, quantification of adducts by RADAR/ELISA produces results comparable to the more cumbersome classical approach of CsCl density gradient fractionation. The experiments reported here establish that RADAR/ELISA assay offers a simple way to characterize Top1 mutants and analyze kinetics of adduct formation and repair. They also provide a foundation for discovery and optimization of drugs that poison bacterial Top1 using standard high-throughput approaches.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibiotic; DNA-Protein crosslink; Gyrase; Mycobacteria; Topoisomerase poison; Tuberculosis

Mesh:

Substances:

Year:  2020        PMID: 32738213      PMCID: PMC9272779          DOI: 10.1016/j.ab.2020.113827

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.191


  33 in total

1.  The acidic triad conserved in type IA DNA topoisomerases is required for binding of Mg(II) and subsequent conformational change.

Authors:  C X Zhu; Y C Tse-Dinh
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

Review 2.  DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.

Authors:  Yves Pommier; Elisabetta Leo; HongLiang Zhang; Christophe Marchand
Journal:  Chem Biol       Date:  2010-05-28

Review 3.  Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics.

Authors:  Yuk-Ching Tse-Dinh
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

Review 4.  New mechanistic and functional insights into DNA topoisomerases.

Authors:  Stefanie Hartman Chen; Nei-Li Chan; Tao-shih Hsieh
Journal:  Annu Rev Biochem       Date:  2013-03-13       Impact factor: 23.643

5.  The DNA relaxation activity and covalent complex accumulation of Mycobacterium tuberculosis topoisomerase I can be assayed in Escherichia coli: application for identification of potential FRET-dye labeling sites.

Authors:  Gagandeep Narula; Jennifer Becker; Bokun Cheng; Neil Dani; Maria V Abrenica; Yuk-Ching Tse-Dinh
Journal:  BMC Biochem       Date:  2010-09-30       Impact factor: 4.059

6.  Isolation and quantitation of topoisomerase complexes accumulated on Escherichia coli chromosomal DNA.

Authors:  Sandra Aedo; Yuk-Ching Tse-Dinh
Journal:  Antimicrob Agents Chemother       Date:  2012-08-06       Impact factor: 5.191

Review 7.  DNA topoisomerase I and DNA gyrase as targets for TB therapy.

Authors:  Valakunja Nagaraja; Adwait A Godbole; Sara R Henderson; Anthony Maxwell
Journal:  Drug Discov Today       Date:  2016-11-14       Impact factor: 7.851

8.  Metalloprotease SPRTN/DVC1 Orchestrates Replication-Coupled DNA-Protein Crosslink Repair.

Authors:  Bruno Vaz; Marta Popovic; Joseph A Newman; John Fielden; Hazel Aitkenhead; Swagata Halder; Abhay Narayan Singh; Iolanda Vendrell; Roman Fischer; Ignacio Torrecilla; Neele Drobnitzky; Raimundo Freire; David J Amor; Paul J Lockhart; Benedikt M Kessler; Gillies W McKenna; Opher Gileadi; Kristijan Ramadan
Journal:  Mol Cell       Date:  2016-10-27       Impact factor: 17.970

9.  Genome-wide mapping of Topoisomerase I activity sites reveal its role in chromosome segregation.

Authors:  Phoolwanti Rani; Valakunja Nagaraja
Journal:  Nucleic Acids Res       Date:  2019-02-20       Impact factor: 16.971

10.  MRN, CtIP, and BRCA1 mediate repair of topoisomerase II-DNA adducts.

Authors:  Tomas Aparicio; Richard Baer; Max Gottesman; Jean Gautier
Journal:  J Cell Biol       Date:  2016-02-15       Impact factor: 10.539

View more
  2 in total

1.  Topoisomerase Assays.

Authors:  John L Nitiss; Kostantin Kiianitsa; Yilun Sun; Karin C Nitiss; Nancy Maizels
Journal:  Curr Protoc       Date:  2021-10

Review 2.  Type IA Topoisomerases as Targets for Infectious Disease Treatments.

Authors:  Ahmed Seddek; Thirunavukkarasu Annamalai; Yuk-Ching Tse-Dinh
Journal:  Microorganisms       Date:  2021-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.